- Report
- March 2024
- 180 Pages
Global
From €3257EUR$3,374USD£2,794GBP
€3619EUR$3,749USD£3,104GBP
- Report
- April 2024
- 193 Pages
Global
From €4778EUR$4,950USD£4,098GBP
- Report
- December 2023
- 200 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- May 2023
- 144 Pages
Global
From €2412EUR$2,499USD£2,069GBP
- Report
- November 2023
- 190 Pages
Global
From €4729EUR$4,900USD£4,057GBP
- Report
- February 2024
- 119 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- December 2022
- 93 Pages
Global
From €5309EUR$5,500USD£4,554GBP
- Report
- January 2022
- 120 Pages
Global
From €2413EUR$2,500USD£2,070GBP
- Report
- August 2022
- 120 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- August 2022
- 81 Pages
Global
From €3500EUR$3,884USD£3,107GBP
Biomarkers are biological molecules that can be used to measure and monitor the progression of a disease or condition. Kidney markers are a type of biomarker used to measure the health of the kidneys. They are typically used to diagnose and monitor kidney diseases, such as chronic kidney disease, acute kidney injury, and glomerulonephritis. Kidney markers can also be used to assess the effectiveness of treatments for kidney diseases.
Kidney markers are typically measured through blood tests, urine tests, or imaging tests. Commonly used kidney markers include creatinine, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL). These markers can be used to measure the level of kidney function, as well as to detect the presence of kidney damage.
The kidney marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of kidney diseases, as well as the growing demand for more accurate and reliable diagnostic tests. The market is expected to continue to grow in the coming years, as new technologies and biomarkers are developed.
Some companies in the kidney marker market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Beckman Coulter. Show Less Read more